West Pharmaceutical Services | WST - Operating Expenses


West Pharmaceutical Services reported $2.99B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Align Technology USD 862.03M 39.18M Mar/2026
Avanos Medical USD 782.1M 625.97M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Repligen USD 174.27M 3.67M Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.97B 3.08B Mar/2026
STAAR Surgical USD 76.12M 7.38M Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Utah Medical Products USD 6.6M 354K Dec/2025
West Pharmaceutical Services USD 2.99B 2.35B Mar/2026